PrEP and PEP: Prevention of HIV Topical Map
Complete topic cluster & semantic SEO content plan — 41 articles, 6 content groups ·
Build a definitive topical hub covering everything clinicians, people at risk, and public-health practitioners need to know about PrEP and PEP — biology, who needs them, how to access and start them, medication details, adherence and STI prevention, and program- and policy-level implementation. Authority is achieved by comprehensive, evidence‑based pillar pages plus targeted clusters that answer high‑intent queries (how-to, eligibility, side effects, access, guidelines, global rollout).
This is a free topical map for PrEP and PEP: Prevention of HIV. A topical map is a complete topic cluster and semantic SEO strategy that shows every article a site needs to publish to achieve topical authority on a subject in Google. This map contains 41 article titles organised into 6 topic clusters, each with a pillar page and supporting cluster articles — prioritised by search impact and mapped to exact target queries.
How to use this topical map for PrEP and PEP: Prevention of HIV: Start with the pillar page, then publish the 21 high-priority cluster articles in writing order. Each of the 6 topic clusters covers a distinct angle of PrEP and PEP: Prevention of HIV — together they give Google complete hub-and-spoke coverage of the subject, which is the foundation of topical authority and sustained organic rankings.
📋 Your Content Plan — Start Here
41 prioritized articles with target queries and writing sequence.
Basics & Comparison: What PrEP and PEP Are and When to Use Them
Explains mechanisms, timing, efficacy and the key differences between PrEP and PEP so readers quickly understand which intervention fits which situation and why timing matters. This group establishes foundational knowledge that other practical articles will reference.
PrEP vs PEP for HIV Prevention: Complete Guide to How They Work, Timing, and Effectiveness
A definitive comparison covering biological mechanisms, windows of opportunity, real‑world and trial efficacy, side effect profiles, and decision algorithms for clinicians and lay readers. The reader will learn when to use PrEP versus PEP, how quickly PEP must start, and realistic expectations of protection.
What is PrEP? A simple explanation, drugs used, and who it's for
Explains PrEP in plain language: drugs (TDF/FTC, TAF/FTC), daily vs on‑demand, indications, and expected protective effect with real-world adherence notes.
What is PEP? Emergency HIV prevention after exposure
Defines PEP, outlines emergency regimens and the 72‑hour window, typical clinic pathways, and follow‑up testing schedule.
PrEP vs PEP: When to use each — scenarios and decision rules
Scenario‑based guidance (e.g., sexual exposure, needle stick, sex without a condom, partner with unknown HIV status) explaining which intervention applies and why.
How effective are PrEP and PEP? Evidence from trials and real life
Summarises key trial results and observational data, explains the role of adherence, and gives numbers needed to treat and real‑world impact estimates.
Emergency timeline: exactly how soon should PEP be started?
Clear, practical timeline and checklist for action in the first hours after potential exposure, including emergency department steps and telephone triage advice.
Common myths about PrEP and PEP (and the facts)
Short myth‑busting article addressing safety, sexual behavior concerns, resistance, and misconceptions.
Eligibility & Special Populations
Covers who should be offered PrEP or PEP and tailored guidance for key populations — women, adolescents, transgender people, people who inject drugs, pregnant/breastfeeding people, and people with comorbidities. Special population guidance is essential for inclusive authority.
Who Should Use PrEP and PEP? Risk Assessment and Guidance for Special Populations
Comprehensive eligibility criteria, validated risk assessment approaches, and tailored recommendations for adolescents, pregnant people, transgender individuals, PWID, serodiscordant couples, and people with renal or hepatic comorbidities. Readers gain clear, actionable criteria to determine candidacy and adjustments needed in special circumstances.
How clinicians assess HIV risk for PrEP: tools and scripts
Actionable risk assessment questionnaires, phrasing for sensitive questions, and a quick clinic triage algorithm to identify candidates for PrEP.
PrEP for women: pregnancy, contraception, and STI considerations
Evidence and recommendations for cisgender women including during pregnancy and breastfeeding, interactions with contraception, and periconception PrEP use.
PrEP and transgender people: tailored guidance
Discusses hormone interaction concerns, culturally competent counselling, and data on safety and effectiveness in transgender populations.
PrEP and adolescents: consent, dosing, and clinical follow‑up
Explains legal consent issues, dosing considerations for younger ages, confidentiality, and parent/guardian counseling strategies.
PrEP for people who inject drugs (PWID): integration with harm reduction
Covers combining PrEP with syringe services, opioid agonist therapy, and priorities for outreach to PWID.
Managing PrEP and PEP in people with kidney disease or hepatitis B
Practical guidance on dosing adjustments, monitoring, and the risk of hepatitis B flares on stopping therapy.
Access, Starting, and Monitoring
Step‑by‑step guides to obtaining PrEP/PEP: where to go, necessary baseline tests, monitoring schedules, telehealth options, insurance and assistance programs, and legal consent topics — everything needed to start and safely continue therapy.
How to Start and Monitor PrEP or PEP: Clinics, Labs, Telehealth and Follow‑Up Schedules
A practical how‑to covering the full patient pathway: finding a clinic, baseline testing (HIV test, renal function, hepatitis serology, STI screening), start protocols, PEP emergency flow, recommended monitoring intervals, and telehealth/mail options. The article empowers both patients and providers to navigate clinical steps and payer systems.
Step‑by‑step: how to start PrEP (what to expect at your first visit)
Clinic checklist for first visit including intake questions, required tests, same‑day start criteria, and counselling points.
How to get PEP after a possible exposure: emergency steps and follow up
Immediate actions to take after exposure, where to present for PEP, typical ED/clinic workflow, and follow‑up schedule.
Laboratory monitoring schedule for PrEP: tests, frequency and abnormal result management
Recommended baseline and follow‑up labs (HIV, creatinine, STIs, pregnancy), interpretation of results, and actions for abnormal findings.
Telehealth and home delivery options for PrEP: pros, cons and how it works
Explains telemedicine models, at‑home specimen collection, mail pharmacy logistics, and regulatory considerations.
Paying for PrEP and PEP: insurance, copay assistance, and patient assistance programs
Steps to navigate insurance coverage, available manufacturer assistance, generic cost comparisons, and tips for uninsured patients.
Consent, confidentiality and minor access laws for PrEP and PEP
Overview of common legal frameworks, confidentiality best practices, and resources by jurisdiction for adolescent access.
Medications, Side Effects & Interactions
Deep dive into the drugs used for PrEP and PEP, comparative safety profiles, drug interactions, management of side effects, and alternatives for people with comorbidities. This technical coverage supports clinicians and informed patients.
PrEP and PEP Medications: Drugs, Dosing, Side Effects, and Drug Interactions
Detailed clinical reference on TDF/FTC (Truvada), TAF/FTC (Descovy), generic formulations, standard PEP regimens and duration, renal and bone safety, and clinically significant drug interactions. Readers get evidence‑based recommendations for managing side effects and choosing regimens for people with comorbidities.
Truvada vs Descovy for PrEP: differences, approvals and who should use which
Comparison of TDF/FTC and TAF/FTC on efficacy, renal and bone safety, FDA approvals and populations not studied or recommended for Descovy.
Generic PrEP options and cost comparison
Lists available generics worldwide, cost differences, bioequivalence considerations, and where generics are available by region.
PEP regimens and duration: first‑line choices and management of side effects
Standard 28‑day PEP regimens (drugs, rationale), alternative regimens, and how to manage common adverse effects to improve completion.
Drug interactions with PrEP and PEP (including hormone therapy)
Clinically relevant interactions (nephrotoxic drugs, anticonvulsants, hormonal therapies) and management strategies.
Managing side effects of PrEP: renal, bone, and GI problems
How to monitor and respond to laboratory abnormalities and common symptoms, including when to change or stop therapy.
PrEP with hepatitis B or C: co‑infection management and flare risk
Guidance on starting/stopping PrEP in people with HBV infection and vaccination and monitoring recommendations.
Adherence, Behavioral Support & STI Prevention
Focuses on adherence strategies (including event‑driven PrEP), behavioural counselling, how PrEP fits into broader sexual health (condoms, STI screening, vaccination), and managing substance‑use related risks.
Adherence and Sexual Health on PrEP: Strategies, On‑Demand Dosing, STI Prevention and Counseling
Covers evidence‑based adherence supports, practical tools (pillboxes, reminders), event‑driven (2‑1‑1) PrEP protocols, integrating STI screening and vaccination, and counselling to reduce risk compensation. Readers learn how to maximize PrEP effectiveness while maintaining overall sexual health.
On‑demand PrEP (2‑1‑1): how it works, who can use it, and exact dosing
Clear instructions for 2‑1‑1 dosing, evidence base, limitations (not recommended for receptive vaginal sex), and how to counsel patients.
PrEP adherence strategies: reminders, support programs and clinic interventions
Practical tactics (SMS reminders, motivational interviewing, peer navigators) and how clinics can measure and support adherence.
STI screening and prevention for people on PrEP: schedule and best practices
Recommended STI screening intervals, extra‑genital testing, partner treatment strategies, and vaccination recommendations (HPV, hepatitis A/B).
Counseling about sex, condoms and risk compensation while on PrEP
How to have nonjudgmental conversations about safer sex, negotiating condom use, and evidence on behavior change after PrEP initiation.
Supporting people who use substances: PrEP delivery with harm reduction services
Integrating PrEP into substance use treatment and syringe service programs, and practical outreach strategies.
Public Health, Policy & Global Implementation
Analyzes guidelines, public‑health impact, program design and funding, stigma and equity issues, and lessons from national rollouts to inform program planners and policy makers.
PrEP and PEP in Public Health: Guidelines, Program Design, Equity, and Global Scale‑Up
Synthesizes official guidelines (CDC, WHO, national), programmatic models for scale‑up, funding and cost‑effectiveness, and strategies to reduce stigma and reach underserved groups. This pillar is for public‑health leaders, funders and implementers who need evidence‑based program blueprints.
Summary of CDC, WHO and major national PrEP/PEP guidelines
Concise comparison table and narrative summarizing recommendations and differences across major guidelines.
Cost‑effectiveness and budget impact of PrEP programs
Synthesizes economic evaluations and shows where PrEP delivers the most value, plus considerations for low‑resource settings.
Case studies: successful national and local PrEP rollouts
Detailed profiles of programs (e.g., US cities, South Africa, UK), what worked, and transferable lessons for implementation.
Addressing stigma and improving equity in PrEP delivery
Strategies to increase uptake in marginalized groups, community engagement approaches, and metrics for measuring equity.
Legal, regulatory and policy barriers to PrEP access and how to overcome them
Overview of common barriers (prescription restrictions, age consent, reimbursement) and policy solutions and advocacy tactics.
Monitoring and evaluation for PrEP/PEP programs: KPIs and data collection
Key performance indicators, data sources, and suggested dashboards for program managers to track uptake, retention, and outcomes.
Full Article Library Coming Soon
We're generating the complete intent-grouped article library for this topic — covering every angle a blogger would ever need to write about PrEP and PEP: Prevention of HIV. Check back shortly.
Strategy Overview
Build a definitive topical hub covering everything clinicians, people at risk, and public-health practitioners need to know about PrEP and PEP — biology, who needs them, how to access and start them, medication details, adherence and STI prevention, and program- and policy-level implementation. Authority is achieved by comprehensive, evidence‑based pillar pages plus targeted clusters that answer high‑intent queries (how-to, eligibility, side effects, access, guidelines, global rollout).
Search Intent Breakdown
Key Entities & Concepts
Google associates these entities with PrEP and PEP: Prevention of HIV. Covering them in your content signals topical depth.
Content Strategy for PrEP and PEP: Prevention of HIV
The recommended SEO content strategy for PrEP and PEP: Prevention of HIV is the hub-and-spoke topical map model: one comprehensive pillar page on PrEP and PEP: Prevention of HIV, supported by 35 cluster articles each targeting a specific sub-topic. This gives Google the complete hub-and-spoke coverage it needs to rank your site as a topical authority on PrEP and PEP: Prevention of HIV — and tells it exactly which article is the definitive resource.
41
Articles in plan
6
Content groups
21
High-priority articles
~6 months
Est. time to authority
What to Write About PrEP and PEP: Prevention of HIV: Complete Article Index
Every blog post idea and article title in this PrEP and PEP: Prevention of HIV topical map — 0+ articles covering every angle for complete topical authority. Use this as your PrEP and PEP: Prevention of HIV content plan: write in the order shown, starting with the pillar page.
Full article library generating — check back shortly.
This topical map is part of IBH's Content Intelligence Library — built from insights across 100,000+ articles published by 25,000+ authors on IndiBlogHub since 2017.
Find your next topical map.
Hundreds of free maps. Every niche. Every business type. Every location.